MCHC (Mean Corpuscular Hemoglobin Concentration)

TNF-α (Tumor Necrosis Factor-alpha)

Immature Granulocytes

Lipoprotein(a) [Lp(a)]

Calcium

Iron Saturation

Fasting Insulin

Monocytes (Absolute)

Cystatin C

BUN/Creatinine Ratio

Vitamin A (Retinol)

Total Protein

MCH (Mean Corpuscular Hemoglobin)

SHBG (Sex Hormone Binding Globulin)

DHA (Docosahexaenoic Acid)

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance)

MCV (Mean Corpuscular Volume)

Total Testosterone

BUN (Blood Urea Nitrogen)

LDL Particle Size

Potassium

Lymphocytes (Absolute)

AST (Aspartate Aminotransferase)

Triglycerides

WBC (White Blood Cell Count)

Copper Serum

RBC Magnesium

Uric Acid

Platelet Count

VLDL Cholesterol (calculated)

Ferritin

Hematocrit

Lactic Acid

Apolipoprotein B

Insulin

RDW (Red Cell Distribution Width)

Basophils (Absolute)

HS-CRP (High-Sensitivity C-Reactive Protein)

ApoA/ApoB Ratio

Neutrophils (Absolute)

Lipoprotein(a) [Lp(a)] is a biomarker used in longevity research to assess cardiovascular health and risk of developing heart disease.

Lipoprotein(a) [Lp(a)]

Lipoprotein(a) [Lp(a)] is a biomarker that has been increasingly recognized for its potential role in predicting longevity. Elevated levels of Lp(a) have been linked to an increased risk of cardiovascular diseases, which are known to impact overall life expectancy. Monitoring Lp(a) levels can provide valuable insights into an individual’s risk for developing age-related health issues and mortality. As part of a comprehensive longevity assessment, measuring and managing Lp(a) levels can be a crucial component in identifying and mitigating potential risk factors for decreased lifespan. Understanding the impact of Lp(a) on longevity can guide personalized interventions to promote healthy aging and extended lifespan.

Biomarker Explained

Lipoprotein(a) (Lp(a)) is a biomarker that has garnered increasing attention due to its potential role in predicting longevity. Elevated levels of Lp(a) have been associated with a higher risk of developing cardiovascular diseases, which are known to impact overall life expectancy. Therefore, monitoring Lp(a) levels can provide valuable insights into an individual’s risk for age-related health issues and mortality. In the context of a comprehensive longevity assessment, the measurement and management of Lp(a) levels can be a critical component in identifying and addressing potential risk factors for decreased lifespan. Understanding the influence of Lp(a) on longevity can help guide personalized interventions to promote healthy aging and extend lifespan. As such, integrating the assessment of Lp(a) levels into longevity evaluations can aid in identifying individuals who may benefit from targeted interventions to mitigate the impact of elevated Lp(a) on their overall lifespan.

Keywords:

Lipoprotein(a), Lp(a), biomarker, longevity, cardiovascular diseases, risk factors, personalized interventions

Complete Patient Intake Form

Continue Browsing Our Offers